Literature DB >> 16234578

The role of the complement system in innate immunity.

Horea Rus1, Cornelia Cudrici, Florin Niculescu.   

Abstract

Complement is a major component of innate immune system involved in defending against all the foreign pathogens through complement fragments that participate in opsonization, chemotaxis, and activation of leukocytes and through cytolysis by C5b-9 membrane attack complex. Bacterias and viruses have adapted in various ways to escape the complement activation, and they take advantage of the complement system by using the host complement receptors to infect various cells. Complement activation also participates in clearance of apoptotic cells and immune complexes. Moreover, at sublytic dose, C5b-9 was shown to promote cell survival. Recently it was also recognized that complement plays a key role in adaptive immunity by modulating and modifying the T cell responses. All these data suggest that complement activation constitutes a critical link between the innate and acquired immune responses.

Mesh:

Substances:

Year:  2005        PMID: 16234578     DOI: 10.1385/IR:33:2:103

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  59 in total

Review 1.  A protective role for innate immunity in autoimmune disease.

Authors:  M C Carroll
Journal:  Clin Immunol       Date:  2000-04       Impact factor: 3.969

2.  Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

Authors:  Tom Sprong; Petter Brandtzaeg; Michael Fung; Anne M Pharo; E Arne Høiby; Terje E Michaelsen; Audun Aase; Jos W M van der Meer; Marcel van Deuren; Tom E Mollnes
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

Review 3.  Studies of antibody and complement function in host defense against bacterial infection.

Authors:  K A Joiner; L F Fries; M M Frank
Journal:  Immunol Lett       Date:  1987-02       Impact factor: 3.685

4.  Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.

Authors:  L Soane; H Rus; F Niculescu; M L Shin
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation.

Authors:  J L Gommerman; D Y Oh; X Zhou; T F Tedder; M Maurer; S J Galli; M C Carroll
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

6.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

7.  C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis.

Authors:  Florin Niculescu; Teodora Niculescu; Horea Rus
Journal:  Exp Mol Pathol       Date:  2004-02       Impact factor: 3.362

8.  Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity.

Authors:  M Drogari-Apiranthitou; E J Kuijper; N Dekker; J Dankert
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  Protective T cell-independent antiviral antibody responses are dependent on complement.

Authors:  A F Ochsenbein; D D Pinschewer; B Odermatt; M C Carroll; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

10.  Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

Authors:  Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more
  73 in total

Review 1.  Complement in neuroprotection and neurodegeneration.

Authors:  Vijay Yanamadala; Robert M Friedlander
Journal:  Trends Mol Med       Date:  2010-01-28       Impact factor: 11.951

2.  Sublytic complement protects prostate cancer cells from tumour necrosis factor-α-induced cell death.

Authors:  L Liu; W Li; Z Li; M Kirschfink
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 3.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 4.  Immune-mediated processes in neurodegeneration: where do we stand?

Authors:  Marc Fakhoury
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

5.  Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo.

Authors:  Chengliang Zhu; Hui Song; Fengxia Xu; Wei Yi; Fang Liu; Xinghui Liu
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

6.  Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo.

Authors:  Ronald S Flannagan; Daniel Aubert; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 7.  Complement: an overview for the clinician.

Authors:  Juan Carlos Varela; Stephen Tomlinson
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

Review 8.  Complement deficiencies in systemic lupus erythematosus.

Authors:  Angela R Bryan; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

9.  The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.

Authors:  Irina Debnath; J Paul Norton; Amelia E Barber; Elizabeth M Ott; Bijaya K Dhakal; Richard R Kulesus; Matthew A Mulvey
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 10.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.